| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/02/2007 | CN1956966A Quinazoline derivatives and therapeutic use thereof |
| 05/02/2007 | CN1956964A Tetrahydro-indazole cannabinoid modulators |
| 05/02/2007 | CN1956962A Tetrahydroisoquinoline sulfonamide derivatives, the preparation method thereof, and the use of the same in therapeutics |
| 05/02/2007 | CN1956958A Aminopyridine derivatives as selective dopamine d3 agonists |
| 05/02/2007 | CN1956954A Novel androgens |
| 05/02/2007 | CN1956952A Histamine H3 receptor agents, preparation and therapeutic uses |
| 05/02/2007 | CN1956721A Quinazolinone derivatives useful as vanilloid antagonists |
| 05/02/2007 | CN1956718A Compositions comprising immunomodulatory compounds for the treatment and management of skin diseases and disorders, and method of using the same |
| 05/02/2007 | CN1955185A Optical active substitution oxyphosphonate salt acetate and its use |
| 05/02/2007 | CN1955176A Optical separation method substituting oxyphosphonate acetate |
| 05/02/2007 | CN1955175A Cumarin derivative and its preparation method and its drug composite and use |
| 05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/02/2007 | CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such |
| 05/02/2007 | CN1313465C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 05/02/2007 | CN1313464C Substituted alkylamine derivatives, preparing method thereof, composition comprising same and use thereof |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/01/2007 | USRE39608 Substituted benzimidazoles and their use as PARP inhibitors |
| 05/01/2007 | US7211695 Trans-1,4-bis{N-[2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethyl]amino}cyclohexane from aminating a dihydroxymethyl phenyl ketone with a diaminophenylene compound and a reducing agent; treating respiratory diseases, asthma, bronchitis, nervous system injury, premature labor |
| 05/01/2007 | US7211673 5-methyl-2-(4-trifluoromethyl-1H-1-pyrazolyl)-4-(5-trifluoromethyl-3-thienyloxy)pyrimidine; broadleaf herbicide |
| 05/01/2007 | US7211672 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 05/01/2007 | US7211671 Substituted 1,3-dihydro-imidazol-2-one and 1,3-dihydro-imidazol-2-thione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 05/01/2007 | US7211669 therapy for depression; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches; drug addition; antiinflammatory agents |
| 05/01/2007 | US7211601 Prevention labor contraction; urogenital disorders |
| 05/01/2007 | US7211595 Substituted imidazoles and thiazoles |
| 05/01/2007 | US7211594 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 05/01/2007 | US7211590 Such as 2-(nitrooxy)ethyl-2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2 -pyridyl)methyl)sulfinyl)benzimidazolecarboxylate; kits; for treating gastrointestinal disorders/ulcers |
| 05/01/2007 | US7211588 N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation |
| 05/01/2007 | US7211587 Administering compounds such as N-{3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(3-isoxazolyl)urea for therapy of malignant tumors |
| 05/01/2007 | US7211586 Substituted tetrahydroisoquinolines |
| 05/01/2007 | US7211581 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 05/01/2007 | US7211580 Compounds, compositions, and methods |
| 05/01/2007 | US7211579 NK-1 receptor antagonists |
| 05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
| 05/01/2007 | US7211576 Diaminothiazoles |
| 05/01/2007 | US7211417 from fermentation of Micromonospora; therapy for bacteria infections |
| 05/01/2007 | CA2301590C 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 05/01/2007 | CA2290893C Magnesium omeprazole |
| 05/01/2007 | CA2283587C Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with n- or c-linked imidazoles |
| 05/01/2007 | CA2244836C Benzoheterocyclic derivatives as antidiabetic and antiobesity agents |
| 05/01/2007 | CA2162630C Sulfonamides |
| 04/26/2007 | WO2007047991A1 Tetrahydroisoquinoline as lxr modulators |
| 04/26/2007 | WO2007047202A1 Substituted heterocyclic compounds with cxcr3 antagonist activity |
| 04/26/2007 | WO2007047177A1 Acyl indoles, compositions containing such compounds and methods of use |
| 04/26/2007 | WO2007046747A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases |
| 04/26/2007 | WO2007046550A1 Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity |
| 04/26/2007 | WO2007045987A1 New anti-malaria derivatives of 4-aminoquinoline |
| 04/26/2007 | WO2007045893A2 Beta adrenergic receptor pharmacophore |
| 04/26/2007 | WO2007045861A1 Cinnoline compounds as inhibitors of phosphodiesterase type iv (pde4) |
| 04/26/2007 | WO2007045844A1 Benzamide compounds useful as histone deacetylase inhibitors |
| 04/26/2007 | WO2007045672A1 Selected cgrp antagonists method for production and use thereof as medicament |
| 04/26/2007 | WO2007045462A2 Novel vanilloid receptor ligands and their use for producing medicaments |
| 04/26/2007 | WO2007028118A3 Nicotinic acid and picolinic acid derived near-infrared fluorophores |
| 04/26/2007 | WO2007025774A3 Cysteine protease inhibitors |
| 04/26/2007 | WO2007023382A3 Pyrimidine amino pyrazole compounds, potent kinase inhibitors |
| 04/26/2007 | WO2007017244A3 A PROCESS FOR THE PURIFICATION OF SUBSTITUTED 2-(2-PYRIDYLMETHYL)SULFINYL-lH-BENZIMIDAZOLE COMPOUNDS BY PRECIPITATION IN THE PRESENCE OF A QUATERNARY AMMONIUM SALT |
| 04/26/2007 | WO2007012479A3 Benzylpiperazine derivates and their medical use |
| 04/26/2007 | WO2006136606A3 Oxindole derivatives |
| 04/26/2007 | WO2006135828A3 Trisubstituted amines as phosphodiesterase 4 inhibitors |
| 04/26/2007 | WO2006099075A3 Certain substituted amides, method of making, and method of use thereof |
| 04/26/2007 | WO2006056953A3 Reversible self-assembly of imbedded metallomacrocycles within a macromolecular superstructure |
| 04/26/2007 | WO2006031676A3 Tricyclic anilide spirohydantoin cgrp receptor antagonists |
| 04/26/2007 | WO2005115991A8 Anti-cytokine heterocyclic compounds |
| 04/26/2007 | WO2005082883A3 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline |
| 04/26/2007 | WO2004069139A3 4-aminopyrimidin-5-yl-methanone derivatives for inhibition of cdk4 activity |
| 04/26/2007 | US20070093659 Methyl-2-[4-methyl-2-(1-methyl-piperidin-4-ylamino)-benzoimidazol-1-ylmethyl]-pyridin-3-ol; antiviral activity |
| 04/26/2007 | US20070093535 Vinyl phenyl derivatives as GLK activators |
| 04/26/2007 | US20070093532 Benzimidazole carboxamides as raf kinase inhibitors |
| 04/26/2007 | US20070093529 Diacylhydrazine derivatives |
| 04/26/2007 | US20070093528 Pyridyltetrahydropyridines and pyridylpiperidines and method of manufacturing them |
| 04/26/2007 | US20070093526 4-Amino-piperidine derivatives as monoamine uptake inhibitors |
| 04/26/2007 | US20070093525 Microsomal triglyceride transfer protein (MTP) inhibitor (S)-2-[(4'-Isopropoxybiphenyl-2-carbonyl)amino]quinoline-6-carboxylic acid {[(4-fluoro-benzyl)methylcarbamoyl]phenylmethyl}amide; treating obesity |
| 04/26/2007 | US20070093522 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide |
| 04/26/2007 | US20070093506 Inhibitors of tyrosine kinases |
| 04/26/2007 | US20070093502 5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 04/26/2007 | US20070093492 Pyrrolidine derivatives |
| 04/26/2007 | US20070093485 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 04/26/2007 | US20070093484 3-Substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators |
| 04/26/2007 | US20070093483 Use of derivatives of 2, 4-dihydro-[1,2,4] triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo) |
| 04/26/2007 | US20070093479 6-chloro-N-(3,3-dimethylbutyl)-5-phenyl-1H-indazol-3-amine; for treating neurodegenerative diseases such as Alzheimer's, fronto-parietal dementia, Pick's disease, Parkinson's disease, type II diabetes, corticobasal degeneration, in which phosphorylation of the tau protein is observed |
| 04/26/2007 | US20070093478 Novel mycobacterial inhibitors |
| 04/26/2007 | US20070093473 7-Heteroarylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 04/26/2007 | US20070093472 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors xa and viia for the treatment of thromboses |
| 04/26/2007 | US20070093467 2-(4-Chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-1-[4-(4-fluorobenzyl),4-hydroxypiperidin-1-yl]ethanone; potent chemokine receptor antagonists; antiinflammatory agents; immunotherapy; rheumatic diseases; antiarthritic agents; transplant rejection; multiple sclerosis |
| 04/26/2007 | US20070093430 Interferons; polyoxyethylene glycol |
| 04/26/2007 | US20070092441 Fluoridation method |
| 04/26/2007 | DE102005050953A1 New piperidine compounds are calcitonin gene-related peptide antagonists used for prophylaxis or treatment of e.g. headache, non-insulin dependent diabetes mellitus and cardiovascular disease |
| 04/26/2007 | DE102005050892A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments |
| 04/26/2007 | DE102005050408A1 Neue Vanilloidrezeptor-Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments |
| 04/26/2007 | CA2628577A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases |
| 04/26/2007 | CA2626789A1 Pyrimidinones as casein kinase ii (ck2) modulators |
| 04/26/2007 | CA2626568A1 Renin inhibitors nitroderivatives |
| 04/26/2007 | CA2626009A1 Selected cgrp antagonists method for production and use thereof as medicament |
| 04/26/2007 | CA2625970A1 Benzamide compounds useful as histone deacetylase inhibitors |
| 04/26/2007 | CA2625762A1 Substituted heterocyclic compounds with cxcr3 antagonist activity |
| 04/26/2007 | CA2625189A1 Novel vanilloid receptor ligands and their use for producing medicaments |
| 04/26/2007 | CA2624007A1 Acyl indoles, compositions containing such compounds and methods of use |
| 04/25/2007 | EP1777225A1 Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/25/2007 | EP1777223A1 Indole derivatives useful as histamine H3 antagonists |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |